Cellectar Biosciences, Inc. - stock earnings
CLRB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -13.7 million USD | ? USD |
| 2023Q2 | -8.2 million USD | ? USD |
| 2023Q1 | -8.5 million USD | ? USD |
| 2022Q4 | -7.2 million USD | ? USD |
| 2022Q3 | -7.8 million USD | ? USD |
| 2022Q2 | -7.4 million USD | ? USD |
| 2022Q1 | -6.1 million USD | ? USD |
| 2021Q4 | -5.9 million USD | ? USD |
| 2021Q3 | -5.8 million USD | ? USD |
| 2021Q2 | -6.0 million USD | ? USD |
| 2021Q1 | -6.4 million USD | ? USD |
| 2020Q4 | -3.6 million USD | ? USD |
| 2020Q3 | -3.9 million USD | ? USD |
| 2020Q2 | -3.6 million USD | ? USD |
| 2020Q1 | -4.0 million USD | ? USD |
| 2019Q4 | -3.4 million USD | ? USD |
| 2019Q3 | -3.9 million USD | ? USD |
| 2019Q2 | -3.2 million USD | ? USD |
| 2019Q1 | -3.6 million USD | ? USD |
| 2018Q4 | -3.8 million USD | ? USD |
| 2018Q3 | -3.0 million USD | ? USD |
| 2018Q2 | -2.9 million USD | ? USD |
| 2018Q1 | -3.5 million USD | ? USD |
| 2017Q4 | -4.1 million USD | ? USD |
| 2017Q3 | -3.5 million USD | ? USD |
| 2017Q2 | -3.1 million USD | ? USD |
| 2017Q1 | -2.9 million USD | ? USD |
| 2016Q4 | -2.6 million USD | ? USD |
| 2016Q3 | -2.3 million USD | ? USD |
| 2016Q2 | -2.1 million USD | ? USD |
| 2016Q1 | 824563 USD | ? USD |
| 2015Q4 | 950913 USD | ? USD |
| 2015Q3 | -1.9 million USD | ? USD |
| 2015Q2 | -2.3 million USD | ? USD |
| 2015Q1 | -2.3 million USD | ? USD |
| 2014Q4 | -2.6 million USD | ? USD |
| 2014Q3 | -505716 USD | ? USD |
| 2014Q2 | -2.1 million USD | ? USD |
| 2014Q1 | -2.9 million USD | ? USD |
| 2013Q4 | -3.9 million USD | ? USD |
| 2013Q3 | -1.3 million USD | ? USD |
| 2013Q2 | -2.1 million USD | ? USD |
| 2013Q1 | -3.5 million USD | ? USD |
| 2012Q4 | -2.2 million USD | ? USD |
| 2012Q3 | -2.1 million USD | ? USD |
| 2012Q2 | -2.2 million USD | ? USD |
| 2012Q1 | -2.4 million USD | ? USD |
| 2011Q4 | -2.0 million USD | -8333 USD |
| 2011Q3 | -1.9 million USD | ? USD |
| 2011Q2 | -2.6 million USD | ? USD |
| 2011Q1 | -598014 USD | 8334 USD |
| 2010Q4 | -598014 USD | 8334 USD |
| 2010Q3 | -1.2 million USD | 8333 USD |
| 2010Q2 | -1.4 million USD | 8333 USD |
| 2010Q1 | 5.4 million USD | 8333 USD |
| 2009Q4 | -10.4 million USD | 19331 USD |
| 2009Q3 | -2.7 million USD | 13702 USD |
| 2009Q2 | -4.9 million USD | 32313 USD |
| 2009Q1 | -1.8 million USD | 30968 USD |
| 2008Q4 | -2.1 million USD | 36445 USD |
| 2008Q3 | -2.5 million USD | 35513 USD |
| 2008Q2 | -4.7 million USD | 45676 USD |
| 2008Q1 | -7.1 million USD | 8333 USD |
| 2007Q4 | -6.5 million USD | ? USD |
| 2007Q3 | -6.4 million USD | ? USD |
| 2007Q2 | -4.2 million USD | ? USD |
| 2007Q1 | -2.4 million USD | ? USD |
| 2006Q4 | -2.7 million USD | ? USD |
| 2006Q3 | -2.8 million USD | 12584 USD |
| 2006Q2 | -1.5 million USD | ? USD |
| 2006Q1 | -1.4 million USD | ? USD |
| 2005Q4 | -704891 USD | -12584 USD |
| 2005Q3 | -954872 USD | 12584 USD |
| 2005Q2 | -982892 USD | ? USD |
| 2005Q1 | -27025 USD | ? USD |
CLRB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -37.7 million USD | ? USD |
| 2022 | -28.6 million USD | ? USD |
| 2021 | -24.0 million USD | ? USD |
| 2020 | -14.8 million USD | ? USD |
| 2019 | -13.9 million USD | ? USD |
| 2018 | -13.2 million USD | ? USD |
| 2017 | -13.6 million USD | ? USD |
| 2016 | -6.2 million USD | ? USD |
| 2015 | -5.5 million USD | ? USD |
| 2014 | -8.1 million USD | ? USD |
| 2013 | -10.8 million USD | ? USD |
| 2012 | -8.8 million USD | ? USD |
| 2011 | -7.4 million USD | -11000 USD |
| 2010 | 2.1 million USD | 33334 USD |
| 2009 | -22.3 million USD | 96314 USD |
| 2008 | -16.5 million USD | 125968 USD |
| 2007 | -19.6 million USD | ? USD |
| 2006 | -8.3 million USD | 12584 USD |
| 2005 | -3.1 million USD | 12584 USD |
CLRB
Price: $3.40
52 week price:
Earnings Per Share: -3.11 USD
P/E Ratio: -1.07
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 27300
Ebitda: -3.4 millionMarket Capitalization: 119.7 million